Unknown

Dataset Information

0

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence.


ABSTRACT: The demonstration of tyrosine kinase inhibitors (TKIs) in treating chronic myeloid leukemia (CML) has heralded a new era in cancer therapeutics. However, a small population of cells does not respond to TKI treatment, resulting in minimal residual disease (MRD); even the most potent TKIs fail to eradicate these cells. These MRD cells serve as a reservoir to develop resistance to therapy. Why TKI treatment is ineffective against MRD cells is not known. Growth factor signaling is implicated in supporting the survival of MRD cells during TKI treatment, but a mechanistic understanding is lacking. Recent studies demonstrated that an elevated c-Fos and Dusp1 expression as a result of convergent oncogenic and growth factor signaling in MRD cells mediate TKI resistance. The genetic and chemical inhibition of c-Fos and Dusp1 renders CML exquisitely sensitive to TKIs and cures CML in both genetic and humanized mouse models. We identified these target genes using multiple microarrays from TKI-sensitive and -resistant cells. Here, we provide methods for target validation using in vitro and in vivo mouse models. These methods can easily be applied to any target for genetic validation and therapeutic development.

SUBMITTER: Kesarwani M 

PROVIDER: S-EPMC6945823 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence.

Kesarwani Meenu M   Kincaid Zachary Z   Azam Mohammad M  

Journal of visualized experiments : JoVE 20190107 143


The demonstration of tyrosine kinase inhibitors (TKIs) in treating chronic myeloid leukemia (CML) has heralded a new era in cancer therapeutics. However, a small population of cells does not respond to TKI treatment, resulting in minimal residual disease (MRD); even the most potent TKIs fail to eradicate these cells. These MRD cells serve as a reservoir to develop resistance to therapy. Why TKI treatment is ineffective against MRD cells is not known. Growth factor signaling is implicated in supp  ...[more]

Similar Datasets

| S-EPMC1177986 | biostudies-literature
| S-EPMC5424814 | biostudies-literature
| S-EPMC3478612 | biostudies-literature
| S-EPMC4884638 | biostudies-literature
| S-EPMC3643847 | biostudies-other
2017-07-17 | PXD005969 | Pride
| S-EPMC3356601 | biostudies-literature
| S-EPMC3932924 | biostudies-literature
| S-EPMC7024087 | biostudies-literature
| S-EPMC1148164 | biostudies-other